Scientific Publications

Key Scientific Publications

Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form

Ekarat Jantratid, Vincenzo De Maio, Emanuela Ronda, Valentina Mattavelli, Maria Vertzoni, Jennifer B. Dressman

European Journal of Pharmaceutical Sciences, Volume 37, Issues 3-4, 28 June 2009, Pages 434-441

Use of the BioDis to generate a physiologically relevant IVIVC

Sandra Klein, Markus W. Rudolph, Brigitte Skalsky, Hans-Ulrich Petereit, Jennifer B. Dressman

Journal of Controlled Release, Volume 130, Issue 3, 24 September 2008, Pages 216-219

Ciproﬂoxacin Dosage and Emergence of Resistance in Human Commensal Bacteria

Bruno Fantin,1,2,3 Xavier Duval,1,4,5,6 Laurent Massias,7 Loubna Alavoine,4,5 Françoise Chau,2 Sylvie Retout,4,6, Antoine Andremont,1,2,8 and France Mentre 1,4,6

JID - 2009:200 (1 August) – Fantin et al

Antibiotic consumption, bacterial resistance and their correlation in a Swiss university hospital and its adult intensive care units

Loeffler, J. M., et al.

Scand.J.Infect.Dis. 35.11-12 (2003): 843-50.

Antibacterial resistance worldwide: causes, challenges and responses

Levy, S. B. and B. Marshall

Nat.Med. 10.12 Suppl (2004): S122-S129

Predictable and unpredictable evolution of antibiotic resistance

Courvalin, P.

J.Intern.Med. 264.1 (2008): 4-16

Contribution of animal models of infection for the evaluation of the activity of antimicrobial agents

Belmatoug, N. and B. Fantin

Int.J.Antimicrob.Agents 9.2 (1997): 73-82

Oral administration of beta-lactamase preserves colonization resistance of piperacillin-treated mice

U. Stiefel, N. J. Pultz, J. Harmoinen, P. Koski, K. Lindevall, M. S. Helfand, and C. J. Donskey

J.Infect.Dis. 188 (10):1605-1609, 2003

Carriage of CTX-M-15-producing Escherichia coli among remote-living children in Senegal

Ruppé E, Woerther PL, Diop A, Sene AM, Da Costa A, Arlet G, Andremont A, Rouveix B

Antimicrob Agents Chemother. 2009 Apr 13

The Maxwell Finland Lecture: for the duration-rational antibiotic administration in an era of antimicrobial resistance and Clostridium difficile

L. B. Rice

Clin Infect Dis 46 (4):491-6, 2008

Inhibition of ampicillin-induced emergence of resistance in intestinal coliforms by targeted recombinant [beta]-lactamase

Silja Mentula, Jaana Harmoinen, Pertti Koski, Elias Westermarck, Merja Rautio, Pentti Huovinen, and Eija Kononen

International Journal of Antimicrobial Agents 24 (6):555-561, 2004

Shedding of Clostridium difficile, fecal beta-lactamase activity, and gastrointestinal symptoms in 51 volunteers treated with oral cefixime

E. Chachaty, C. Bourneix, S. Renard, M. Bonnay, and A. Andremont

Antimicrobial agents and chemotherapy 37 (7):1432-5, 1993

Dose dependence of emergence of resistance to linezolid in Enterococcus faecalis in vivo

Bourgeois-Nicolaos N, Massias L, Couson B, Butel MJ, Andremont A, Doucet-Populaire F

J Infect Dis. 2007 May 15;195(10):1480-8

Antimicrobial resistance in commensal flora of pig farmers

H. Aubry-Damon, K. Grenet, P. Sall-Ndiaye, D. Che, E. Cordeiro, M. E. Bougnoux, E. Rigaud, Y. Le Strat, V. Lemanissier, L. Armand-Lefevre, D. Delzescaux, J. C. Desenclos, M. Lienard, and A. Andremont

Emerging infectious diseases 10 (5):873-9, 2004

Commensal Flora May Play Key Role in Spreading Antibiotic Resistance

A. Andremont

ASM news 69 (12):601-607, 2003

Bud bugs report

IDSA

July 2004

Antibiotic discovery : state of the state. Overcoming our vulnerability because of the downturn in corporate antibacterial R&D could depend on regulatory and legistative reforms

D. M. Shlaes, S. J. Projan, and J. E. Edwards, Jr.

ASM news 70 (6):275-281, 2004

Why it is important to continue antibacterial drug discovery

K. Bush